• Age-related blindness: How a revolutionary eye-drop can address the problem
    According to a review of the global prevalence of age-related macular degeneration AMD and disease burden projection for 2020 and 2040, Asia will see the largest projected number of cases of AMD – and this is expected to increase more rapidly than other regions.
  • 3 diagnostic mysteries solved through DNA sequencing
    DNA sequencing tools have now become more powerful, evidently, as they have begun to solve diagnostic mysteries from identifying brain parasites to discovering risk genes related to Tourette syndrome.
  • News Bites: Microneedle patch could replace flu vaccines, Tick saliva could pave way for a range of new drugs
    This week, Novartis proves targeting inflammation could reduce incidence of heart diseases in a 10,000-patient study. British researchers suggest that inserting a plastic film into the stomach could cure or control diabetes and US scientists and engineers have developed a new microscope that could help surgeons remove breast tumours – completely.
  • Revisiting the Human Genome Project and other health studies for a more holistic view of genetic diseases
    With today's technology, it is found that the human genome that was deemed "completely sequenced" in 2003, is in fact incomplete. Nobody paid much attention to the details as the missing sequences did not seem to matter. However, new findings suggest that they may play a role in conditions such as cancer and autism. Future research projects such as "The Human Project" might also help in demystifying genetic diseases.
  • News Bites: Preeclampsia may be linked to babies' DNA, Vaccine can lower "bad" cholesterol and heart attacks
    This week, a DNA-based vaccine developed in caterpillar cells have been found to better protect against flu infection compared to conventional methods. A three-in-one blood test has also been developed, which may increase the survival rates for prostate cancer patients, and it has been found that statin use is linked to higher risks of developing Parkinson's disease.
  • The medical industry’s newest problem – counterfeit medical devices
    As the world’s technological prowess increases, so too does the world of counterfeit medical supplies. From pharmaceutical drugs to medical devices, the supply chain is being flooded with fakes putting both patients and manufacturers at risk.
  • Hospitals may be investing too much in technology and IT systems
    Today, most medical records are computerised into electronic health records (EHRs). Most EHRs aim to serve patients' needs and healthcare providers' needs as well. But the safety and quality of healthcare has been compromised as hospitals have invested in technologies that fail to share data, failing to better support clinical care.
  • Ensuring the safety of digital healthcare
    As mobile technology continues to develop and solve daily-life problems, healthcare is also getting the digital treatment. But are these medical devices and apps safe for patients and effective?
  • News Bites: Implanting pig cells into brains to slow down Parkinson's Disease, Aspirin may lower breast cancer risk
    This week, a British study suggests foetuses respond to face-like patterns. The NHS has launched the world's first trial of 3D printed bionic hands for children, and a study in rats suggests that photosynthetic bacteria may reduce heart damage during heart attack.
  • Keeping abreast with 4 new breast cancer discoveries
    Time and technology is serving the world of breast cancer well as more and more findings are successfully being discovered. Here is a look at 4 of such discoveries, which are set to change the scene – benefiting both the doctors and patients.
  • Malaysian university aims to produce cost-effective haemodialysers by 2019
    Universiti Teknologi Malaysia (UTM) has created a prototype haemodialyser and plans to mass-produce locally made dialysis machines in the coming years.
  • Reality TV might be the new way for the pharma industry to advertise
    Drug manufacturer MannKind has had trouble marketing its sole product, an insulin-inhaler. Burning through millions of dollars each month, it has decided to change its strategy by sponsoring a reality TV show that aims at helping type 2 diabetic participants to restore their health. Will it be an absolute flop?
  • Notable cancer discoveries from ASCO 2017
    Here, we look at a few of the biggest discoveries from the American Society of Clinical Oncology (ASCO)’s annual meeting earlier this year.